Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
10/2003
10/21/2003US6635618 Glycopeptide phosphonate derivatives
10/16/2003WO2003084983A1 Process for producing modified peptide
10/02/2003US20030187186 Glycopeptide and preparation thereof
10/01/2003EP1347953A2 Agents and methods for promoting bone growth
09/2003
09/25/2003WO2002085307A3 Glycopeptide antibiotics
09/25/2003US20030180734 Peptide nucleic acids
09/24/2003EP1123109B1 Contulakin-g, analogs thereof and uses therefor
09/18/2003WO2003076460A1 A process for the production of ramoplanin-like amide derivatives
09/18/2003US20030176639 Peptide-based compounds
09/18/2003US20030175996 Peptide fructose and complex thereof with binding protein
09/18/2003US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis
09/18/2003CA2476567A1 A process for the production of ramoplanin-like amide derivatives
09/17/2003EP1343814A2 Immunogenic glycopeptides, screening, preparation and uses
09/16/2003US6620781 Glycopeptide carboxy-saccharide derivatives
09/11/2003US20030170843 Carbohydrate crosslinked glycoprotein crystals
09/10/2003CN1441680A Cyclodextrin containing glycopeptide antibiotic pharmaceutical compositions
09/04/2003WO2003072058A2 Dna-binding polyamide drug conjugates
09/04/2003WO2003029270A3 Process for preparing glycopeptide phosphonate derivatives
08/2003
08/28/2003WO2003070756A2 Novel glycopeptide antibiotics and method for synthesis thereof
08/28/2003WO2003031449A3 Cross-linked glycopeptide-cephalosporin antibiotics
08/28/2003WO2002043771A3 Conjugates of glycosylated/galactosylated peptide
08/28/2003WO2002026776A3 Peptide-based compounds
08/27/2003EP1157030B1 Echinocandin/carbohydrate complexes
08/21/2003US20030158093 For therapy of bacterial infections
08/21/2003US20030157115 Carrier with a dendrimeric poly-Lysine enabling multiple epitopes to be covalently attached thereto, a peptide with t epitope(s) and a carbohydrate with a b epitope that is not a sialoside; immunotherapy
08/20/2003EP0809652B1 New combined process for the purification of vancomycin hydrochloride
08/20/2003CN1437611A 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives
08/14/2003US20030153492 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
08/13/2003EP1334117A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
08/07/2003WO2003064454A1 Fap-activated anti-tumor compounds
08/07/2003US20030149262 Benzodiazepine vitronectin receptor antagonist pharmaceuticals
08/07/2003CA2472296A1 Fap-activated anti-tumor compounds
08/06/2003EP1333033A1 FAP-activated anti-tumor compounds
08/05/2003US6602982 Process for the preparation of regular glycopeptides
07/2003
07/31/2003US20030143662 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
07/31/2003US20030143235 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
07/23/2003CN1432023A Reductive alkylation process on glycopeptides
07/22/2003CA2109320C Peptide nucleic acids
07/17/2003WO2002058589A3 Agents and methods for promoting bone growth
07/16/2003EP1326983A2 Gene cluster for ramoplanin biosynthesis
07/16/2003EP0830137B1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
07/10/2003US20030130174 Antiinflammatory agents; rheumatic diseases; anticholesterol agents
07/10/2003US20030130173 Bactericides for drug resistant bacteria
07/10/2003US20030130172 Novel lipoglycopeptide antibiotics
07/10/2003US20030129683 Bacterial transglycosylases: assays for monitoring the activity using Lipid II substrate analogs and methods for discovering new antibiotics
07/09/2003EP0964690B1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
07/09/2003CN1429121A Polyglutamic acid-camptothecin conjugates and methods of preparation
07/03/2003US20030124120 Quinolone vitronectin receptor antagonist pharmaceuticals
06/2003
06/26/2003US20030119722 Process for purifying glycopeptide phosphonate derivatives
06/25/2003EP0871650B1 Solid phase organic synthesis
06/24/2003CA2250578C Improved chemical process for preparing amide derivatives of antibiotic a 40926
06/19/2003US20030114361 Antithrombotic compound
06/17/2003US6579696 Comprising diaminobutyric acid having a gamma amino group and amino acid selected from cysteine, alanine and lysine; use in prevention and treatment of sepsis
06/11/2003EP1140993B1 Glycopeptide derivatives and pharmaceutical compositions containing the same
06/05/2003WO2003046150A2 Glycoprotein remodeling using endoglycanases
06/05/2003WO2003045980A2 Glycopeptide remodeling using amidases
06/05/2003US20030104986 Streptomycin bactericides for treating infections; cultures
06/05/2003US20030104985 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates
06/05/2003CA2468230A1 Glycopeptide remodeling using amidases
06/04/2003CN1422279A Selective N-acylation of A82846 glycopeptide analogs
06/03/2003CA2076424C Phosphoinositol-glycan-peptide with insulin-like action
05/2003
05/28/2003EP1106626B1 Process for the preparation of regular glycopeptides
05/27/2003US6569402 Vitronectin receptor antagonist pharmaceuticals
05/22/2003WO2003042247A2 Modified anti-tnf alpha antibody
05/22/2003CA2466592A1 Modified anti-tnf alpha antibody
05/21/2003EP1311281A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
05/15/2003WO2002088318A3 Lipid-comprising drug delivery complexes and methods for their production
05/15/2003US20030092610 Culturing a glycopeptide antibiotic-producing strain of Streptomyces hygroscopicus under aerobic conditions and recovering the antibiotic; specific strains of microorganism; antibiotic is cyclic peptide with 2-iminoimidazolidine groups
05/14/2003EP1309336A1 Derivatives of laspartomycin and preparation and use thereof
05/14/2003CN1416896A Tumor CT antigen immune inducing agent for treating liver cancer and its prepn
05/08/2003US20030087874 Antibiotic AA 896 analogs
05/08/2003US20030087812 Glycopeptide antibiotics
05/08/2003US20030087232 Methods for screening polypeptides
05/06/2003US6558649 Vitronectin receptor antagonist pharmaceuticals
05/06/2003CA2126691C Gapped 2' modified oligonucleotides
05/01/2003US20030083235 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents
04/2003
04/24/2003WO2003032925A2 Glycosulfopeptide inhibitors and methods of use thereof
04/24/2003WO2003018608A8 Process for purifying glycopeptide phosphonate derivatives
04/24/2003US20030078398 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
04/24/2003US20030077670 Homogeneous assay of vancomycin using a stable particle-vancomycin conjugate, a novel rate enhancer, and a novel dose response modulator
04/17/2003WO2003031464A2 Remodeling and glycoconjugation of peptides
04/17/2003WO2003031449A2 Cross-linked glycopeptide-cephalosporin antibiotics
04/17/2003US20030073157 Synthetic peptides, conjugation reagents and methods
04/16/2003EP1302477A1 Peptide fructose and complex thereof with binding protein
04/15/2003US6548663 Benzodiazepine vitronectin receptor antagonist pharmaceuticals
04/10/2003WO2003029270A2 Process for preparing glycopeptide phosphonate derivatives
04/10/2003US20030069391 Process for preparing glycopeptide phosphonate derivatives
04/08/2003CA2098098C Tetrapeptides deriving from dalbaheptide antibiotics
04/03/2003WO2003026589A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
04/03/2003US20030064492 Nucleotide sequences for use as tool in human therapeutics and diagnostics
04/02/2003EP1296678A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
04/02/2003CN1407989A Antithrombotic compound
03/2003
03/27/2003US20030060598 Glycopeptide derivatives and pharmaceutical compositions containing the same
03/20/2003US20030054983 Antibiotics AA-896
03/20/2003US20030054508 Substantially pure glycopeptide antibotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 AND AC-98-5
03/19/2003EP1292612A2 Glycopeptide phosphonate derivatives
03/19/2003EP1292611A2 Glycopeptide carboxy-saccharide derivatives
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/06/2003WO2003018608A2 Process for purifying glycopeptide phosphonate derivatives
03/06/2003WO2003018607A2 Process for preparing glycopeptide derivatives
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 34